Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Pfizer
Pfizer
University of Zurich
Peking University Cancer Hospital & Institute
OHSU Knight Cancer Institute
Centre Georges Francois Leclerc
Second Life Therapeutics
Onchilles Pharma Inc
Ohio State University Comprehensive Cancer Center
OncoHost Ltd.
Petrov, Andrey
Hangzhou DAC Biotechnology Co., Ltd.
Xynomic Pharmaceuticals, Inc.
The University of Hong Kong-Shenzhen Hospital
Convalife (Shanghai) Co., Ltd.